Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,94 USD | -6,73% |
|
-11,82% | -53,81% |
Vakgebied
Aantal werknemers: 9
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Sapirstein
CEO | Chief Executive Officer | 63 | 08-10-19 |
Sarah Romano
DFI | Director of Finance/CFO | 44 | 01-03-22 |
Amy Chandler
CMP | Compliance Officer | 56 | - |
Martin Krusin
PRN | Corporate Officer/Principal | - | 01-01-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 78 | 03-03-17 | |
Ed Borkowski
BRD | Director/Board Member | 64 | 01-05-15 |
Alastair Riddell
BRD | Director/Board Member | 74 | 01-09-15 |
James Sapirstein
CEO | Chief Executive Officer | 63 | 08-10-19 |
Mary Coelho
BRD | Director/Board Member | 62 | 11-08-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 475 090 | 2 294 472 ( 92,70 %) | 0 | 92,70 % |
Bedrijfsgegevens
First Wave Biopharma, Inc.
777 Yamato Road Suite 502
33431, Boca Raton
+561 589 7020
http://www.firstwavebio.com![Adres Entero Therapeutics, Inc.(ENTO)](https://cdn.zonebourse.com/static/address/30506551.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-53,81% | 4,8 mln. | |
+34,01% | 51,07 mld. | |
+33,84% | 38,86 mld. | |
-8,02% | 38,78 mld. | |
-8,98% | 26,69 mld. | |
+12,56% | 26,35 mld. | |
-19,62% | 19,46 mld. | |
+39,18% | 13,58 mld. | |
+31,47% | 12,46 mld. | |
-3,40% | 11,75 mld. |
- Beurs
- Aandelen
- Koers ENTO
- Onderneming Entero Therapeutics, Inc.